Performance and Clinical Decision-Making Using the Prognostic 40-Gene Expression Profile (40-GEP) Test in 1,018 Patients With High-Risk Cutaneous Squamous Cell Carcinoma (SCC). J of Skin 2022, 6 (6), s96. https://doi.org/10.25251/skin.6.supp.96.